At Auna, we believe innovation is meaningful when it improves and extends people’s lives. Technology, no matter how sophisticated, has no value if it does not translate into better clinical outcomes, a more human experience for patients, and greater opportunities for access to quality care that contributes to their well-being.
Today, we face one of the most important health challenges of our time. Cancer continues to grow in incidence and complexity, putting pressure on health systems around the world and forcing us to rethink how we diagnose, treat, and support those living with this disease.
In Mexico, cancer is already the third leading cause of death in the country, with more than 207,000 new cases recorded each year. If current trends continue, diagnoses could grow by nearly 90% by 2050, approaching 393,000 cases annually. In this scenario, it is essential to build a virtuous circle that brings together specialized care, more precise technologies, timely diagnosis, comprehensive support for patients, and assistance for their caregivers and families.
The response cannot be limited solely to treating the disease. It must include a comprehensive vision that strengthens people’s quality of life throughout their care journey. This means understanding that behind every diagnosis there is a person, a family, and an economic reality that also face enormous challenges.
For this reason, our responsibility as a health institution is to look beyond the clinical sphere. We are convinced that innovation in oncology must be accompanied by mechanisms that facilitate effective access to care and reduce families’ financial vulnerability in the face of a cancer diagnosis. From our position, we work to promote new coverage models and strategies that help expand access to specialized services, strengthen continuity of care, and offer greater financial protection to households facing one of the most complex moments of their lives.
As a hospital group, we understand that the future of cancer care will be increasingly personalized, predictive, and centered on each patient’s needs. That future is already taking shape thanks to advances that make it possible to adapt treatments based on each individual’s progress, rather than relying solely on a plan designed weeks in advance.
One example of this transformation is adaptive radiotherapy, an evolution that incorporates artificial intelligence, advanced medical imaging, and data analysis to adjust treatment as the patient’s clinical conditions change. Beyond the technological complexity, what truly matters is that this capability enables more precise decision-making and a more timely response to the individual needs of each case.
For decades, radiotherapy has been one of the most effective tools for fighting cancer. Thanks to it, millions of people around the world have received successful treatments. However, medicine is constantly evolving, and today we have resources that allow us to further refine that precision.
The ability to identify changes in the size of a tumor, the position of nearby organs, or other patient conditions before each session represents a new way of understanding medicine. It is the shift from a reactive model to one capable of adapting in real time to each person’s needs.
At Auna, we think this is the path medical care must follow. That is why we promote innovation and research to bring more precise, human, and effective solutions closer to people. Our goal is to incorporate advances that not only raise clinical standards but also transform the experience of patients and their families throughout the entire care process.
However, it would be a mistake to think that transformation depends solely on technology. Investment in innovation must be accompanied by medical talent. No digital platform can replace clinical judgment, the experience of specialists, or the human capacity to make complex decisions. Artificial intelligence can process information at great speed, but it is physicians who interpret that data, place it in context, and turn it into responsible decisions for each patient.
That is why, when we talk about the future of oncology, we also talk about continuous training, multidisciplinary work, and institutional strengthening. Technology is a tool; the true differentiator remains the quality and professionalization of the talent that uses it.
Our responsibility as health organizations is not limited to incorporating state-of-the-art equipment. It also involves developing environments capable of ensuring that these innovations generate real clinical value, operate under the highest safety standards, and help improve the quality of care for a greater number of people.
At Auna, we understand innovation as a permanent commitment to better outcomes for patients. This means constantly evaluating new solutions, strengthening our teams’ capabilities, and promoting care models in which science, technology, and people’s abilities work in an integrated way.
We also emphasize that the future of the health system will depend on our ability to integrate data, clinical intelligence, technological innovation, and multidisciplinary collaboration. The magnitude of the challenge demands it. According to the WHO, new cancer cases could reach 35 million per year globally by 2050; in addition, ten types of malignant neoplasms accounted for nearly two-thirds of new diagnoses and deaths recorded worldwide in 2022.
In the face of this reality, health systems must evolve toward more precise, preventive, and personalized care models, capable not only of responding to growing demand but also of generating better outcomes for patients and their families. Innovation fulfills its purpose when it enables us to anticipate disease, better support people, and make more timely and effective clinical decisions.
For Mexico, this evolution represents a strategic opportunity. Bringing world-class innovation closer, strengthening specialized medical infrastructure, promoting the development of highly trained talent, and expanding access mechanisms will be determining factors in responding to the growth of increasingly complex diseases.
The deeper conversation is not technological; it is human. It is about how we use knowledge, innovation, and institutional capacity to offer better opportunities for life to those who need them most.
The medicine of the future will be more precise, personalized, and predictive. But true progress will not lie solely in the ability to treat a disease with greater accuracy, but in our ability to care for people comprehensively. It means preventing whenever possible, diagnosing in a timely manner, treating with precision, providing support throughout the entire process, and protecting the quality of life of patients and their families.
Innovation must help us build a care model that supports patients before, during, and after treatment, integrating prevention, diagnosis, specialized care, and financial protection. Because the health of the future will not be defined only by our ability to cure, but by our ability to provide better care, for longer, and in an increasingly human way.
